These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2035867)

  • 21. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir.
    Jakeman B; Conklin J; Bouchonville M; Thornton K
    J Am Pharm Assoc (2003); 2015; 55(2):193-7. PubMed ID: 25658506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
    N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cushing's syndrome: complication of triamcinolone injection for urethral strictures in children.
    Augspurger RR; Wettlaufer JN
    J Urol; 1980 Jun; 123(6):932-3. PubMed ID: 7382013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    JAMA; 1979 Oct; 242(15):1640-3. PubMed ID: 39183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
    Mendilaharzu H; Gregory T; Gardner LI
    J Pediatr; 1973 Jul; 83(1):69-76. PubMed ID: 4358656
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
    Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF
    J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 30. Remission of Cushing's disease after administration of adrenocorticotropin.
    Pratt JH; Sawin CT; Melby JC
    Am J Med; 1974 Dec; 57(6):949-52. PubMed ID: 4139895
    [No Abstract]   [Full Text] [Related]  

  • 31. Spinal epidural lipomatosis: a serious complication of iatrogenic Cushing's syndrome.
    Kaplan JG; Barasch E; Hirschfeld A; Ross L; Einberg K; Gordon M
    Neurology; 1989 Aug; 39(8):1031-4. PubMed ID: 2668785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion.
    Pralong FP; Gomez F; Guillou L; Mosimann F; Franscella S; Gaillard RC
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3817-22. PubMed ID: 10523036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease.
    Schlechte JA; Sherman B; Pfohl B
    Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A toxicity study with beclomethasone dipropionate in the dog with particular reference to the respiratory tract.
    Poynter D; Spurling NW; Ainge G
    Postgrad Med J; 1975; 51 Suppl 4():27-9. PubMed ID: 1197192
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J; Valette A; Latrabe J; Codaccioni JL
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 38. [Various mechanisms of disorders of the hypothalamo-hypophyseal-adrenal system in Cushing's syndrome].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1978; 24(1):30-5. PubMed ID: 204919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE; Rosenfeld PS; Bokat MA
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Topical corticosteroid therapy in Cushing's syndrome].
    Haim S; Zamir B; Dickstein G; Barzilai D
    Harefuah; 1981 Nov; 101(9):216. PubMed ID: 7347301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.